AAAAAA

   
Results: 1-9 |
Results: 9
Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk
Authors: Brekelmans, CTM Seynaeve, C Bartels, CCM Tilanus-Linthorst, MMA Meijers-Heijboer, EJ Crepin, CMG van Geel, AN Menke, M Verhoog, LC van den Ouweland, A Obdeijn, IM Klijn, JGM
Citation: Ctm. Brekelmans et al., Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk, J CL ONCOL, 19(4), 2001, pp. 924-930
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
Authors: Meijers-Heijboer, H van Geel, B van Putten, WLJ Henzen-Logmans, SC Seynaeve, C Menke-Pluymers, MBE Bartels, CCM Verhoog, LC van den Ouweland, AMW Niermeijer, MF Brekelmans, CTM Klijn, JGM
Citation: H. Meijers-heijboer et al., Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation., N ENG J MED, 345(3), 2001, pp. 159-164
Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients
Authors: Verhoog, LC Berns, EMJJ Brekelmans, CTM Seynaeve, C Meijers-Heijboer, EJ Klijn, JGM
Citation: Lc. Verhoog et al., Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients, J CL ONCOL, 18(21), 2000, pp. 119S-124S
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation
Authors: Meijers-Heijboer, EJ Verhoog, LC Brekelmans, CTM Seynaeve, C Tilanus-Linthorst, MMA Wagner, A Dukel, L Devilee, P van den Ouweland, AMW van Geel, AN Klijn, JGM
Citation: Ej. Meijers-heijboer et al., Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation, LANCET, 355(9220), 2000, pp. 2015-2020
Genetic testing and prophylactic surgery in familiar clusters of BRCA1 or BRCA2 mutation
Authors: Meijers-Heijboer, EJ Verhoog, LC Brekelmans, CTM Seynaeve, C Tilanus-Linthorst, MMA Wagner, A Dukel, L Devilee, P van den Ouweland, AMW van Geel, AN Klijn, JGM
Citation: Ej. Meijers-heijboer et al., Genetic testing and prophylactic surgery in familiar clusters of BRCA1 or BRCA2 mutation, GYNAKOLOGE, 33(10), 2000, pp. 768-769
Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
Authors: Verhoog, LC Brekelmans, CTM Seynaeve, C Meijers-Heijboer, EJ Klijn, JGM
Citation: Lc. Verhoog et al., Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer, BR J CANC, 83(3), 2000, pp. 384-386
Family history of breast cancer and local recurrence after breast-conserving therapy
Authors: Brekelmans, CTM Voogd, AC Botke, G van Geel, BN Rodrigus, P Rutgers, EJT Klijn, JGM Coebergh, JW
Citation: Ctm. Brekelmans et al., Family history of breast cancer and local recurrence after breast-conserving therapy, EUR J CANC, 35(4), 1999, pp. 620-626
Survival in hereditary breast cancer associated with germline mutations ofBRCA2
Authors: Verhoog, LC Brekelmans, CTM Seynaeve, C Dahmen, G van Geel, AN Bartels, CCM Tilanus-Linthorst, MMA Wagner, A Devilee, P Halley, DJJ van den Ouweland, AMW Meijers-Heijboer, EJ Klijn, JGM
Citation: Lc. Verhoog et al., Survival in hereditary breast cancer associated with germline mutations ofBRCA2, J CL ONCOL, 17(11), 1999, pp. 3396-3402
Breast cancer screening in high-risk women
Authors: Brekelmans, CTM Bartels, CCM Crepin, E van Geel, AN Meijers-Heijboer, H Seynaeve, C Tilanus-Linthorst, MMA Verhoog, LC Wagner, A Klijn, JGM
Citation: Ctm. Brekelmans et al., Breast cancer screening in high-risk women, DIS MARKER, 15(1-3), 1999, pp. 34-36
Risultati: 1-9 |